Solution serializes, finds fakes

Oracle and New Momentum are collaborating to help drug makers combat counterfeits. The effort is expected to offer pharmaceutical companies the ability to track units through the supply chain as well as quickly find the fakes.

The enterprise software giant is developing a manufacturing solution that provides for the serialization of each sellable unit of a drug and the tracking of that unit through the supply chain via electronic pedigree. New Momentum, for its part, is integrating its real-time view of counterfeit suspects, which aids manufacturers in proactive anti-counterfeiting efforts while maintaining compliance with serialization and pedigree mandates.

"The best way to meet counterfeiting challenges is to integrate internal enterprise and supply chain data with external data on counterfeit suspects and activity," says New Momentum CEO Stuart Clifton.

Prototypes will be demonstrated next week at Oracle OpenWorld in San Francisco.

- here's the release

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.